• Estradiol-ERα Axis Restores CD4+ T Cell Function After Shock

  2026-08-04

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte proliferation and cytokine production after hemorrhagic shock by inhibiting endoplasmic reticulum stress via ERα and GPR30, but not ERβ. The findings clarify estrogen receptor subtype involvement in immune recovery, suggesting new avenues for immune modulation in trauma and shock contexts.

• Z-VAD-FMK in Apoptosis Inhibition: Protocols and Innovations

  2026-08-03

  Z-VAD-FMK enables researchers to dissect apoptotic pathways with precision, offering robust caspase inhibition for both in vitro and in vivo models. This guide details optimized workflows, troubleshooting strategies, and novel insights from recent mechanistic studies, helping you maximize experimental reproducibility and data clarity.

• Pseudo-UTP: Redefining RNA Stability and Immunogenicity Cont

  2026-08-03

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) enables precise control of RNA stability and immunogenicity in advanced research. This article delivers a mechanistic deep dive, revealing how Pseudo-UTP transforms in vitro transcription and mRNA vaccine design.

• Calpain Inhibitor II, ALLM: Protease Regulation in Cancer Mo

  2026-08-02

  Explore how Calpain Inhibitor II, ALLM empowers apoptosis and protease inhibition studies in leukemia, lymphoma, and advanced cancer biology. Discover new mechanistic insights and optimal assay strategies for translational research.

• In Vitro Activity of Sisomicin vs. Kanamycin in Clinical Iso

  2026-08-01

  The referenced study systematically compared the in vitro antimicrobial activity of sisomicin, a newly identified aminoglycoside, to established antibiotics including kanamycin, gentamicin, and tobramycin across 565 clinical bacterial isolates. The findings demonstrate sisomicin’s superior efficacy over kanamycin against most gram-negative bacilli, informing both mechanistic understanding and practical antibiotic selection in research and clinical microbiology.

• Biochemical Roles of CARMIL's Membrane-Binding Domain in Act

  2026-07-31

  This study uncovers how the membrane-binding (MB) domain of CARMIL orchestrates actin regulation by targeting and releasing capping protein (CP) at membranes, thus facilitating Arp2/3-mediated actin assembly. The findings clarify unresolved mechanisms of CP activation and release, with implications for cytoskeletal research and recombinant protein workflows.

• Hematoxylin and Eosin Staining Kit: Precision in Tissue Morp

  2026-07-31

  The Hematoxylin and Eosin Staining Kit from APExBIO streamlines robust tissue morphology visualization across paraffin and frozen sections, enabling high-contrast, reproducible nuclear and cytoplasmic staining. Its ready-to-use formulation and workflow adaptability empower advanced histopathological analysis and troubleshooting in research settings.

• Practical Guide: Anti-HMGB1 Rabbit Monoclonal Antibody (MA30

  2026-07-30

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) offers specific detection of HMGB1 protein in human, mouse, and rat samples for research workflows, including Western blot, immunohistochemistry, and flow cytometry. This reagent addresses the need for reliable HMGB1 detection in chromatin studies but should not be used for diagnostic or therapeutic purposes.

• Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision in Multipl

  2026-07-30

  The Cy3 Goat Anti-Human IgG (H+L) Antibody empowers researchers with unrivaled sensitivity and workflow versatility across immunofluorescence, IHC, flow cytometry, and ELISA. Its Cy3 conjugation ensures robust, reproducible detection of human IgG, even in challenging multiplexed or low-abundance systems.

• Gene Expression Profiling Predicts PARP Inhibitor Response i

  2026-07-29

  Borchert et al. (2019) demonstrate that defects in homologous recombination repair (HRR), described as BRCAness, are frequent in malignant pleural mesothelioma (MPM) and can predict susceptibility to PARP inhibitor therapy. Their gene expression profiling approach identifies patient subgroups potentially responsive to olaparib, with implications for stratified treatment strategies and future combination protocols.

• Eltanexor (KPT-8602): Shaping Cancer Research via Nuclear Ex

  2026-07-29

  Eltanexor (KPT-8602) is redefining the landscape of cancer therapeutics by targeting XPO1-mediated nuclear export. This thought-leadership article blends mechanistic insight with practical guidance for translational researchers, integrating the latest evidence on Eltanexor's impact on signaling pathways, experimental optimization, and its emerging role in chemoprevention. With a focus on actionable strategy and translational opportunity, we examine how APExBIO’s Eltanexor empowers the field beyond conventional product coverage.

• Bafilomycin C1 in Phenotypic Drug Discovery: Beyond Autophag

  2026-07-28

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, is revolutionizing phenotypic drug discovery through advanced assay design and high-content screening. Discover unique insights into its mechanistic role in cellular signaling and practical guidance for optimizing experiments.

• Bivalent mRNA Vaccine RQ3025: Broad Protection Against SARS-

  2026-07-28

  The referenced study introduces RQ3025, a bivalent mRNA vaccine designed to induce broad-spectrum immunity against diverse SARS-CoV-2 variants in animal models. This preclinical work highlights the vaccine’s capacity to elicit high-titer neutralizing antibodies and a Th1-skewed cellular response, offering a promising strategy for addressing ongoing viral evolution.

• TPPU and the sEH–Nrf2 Axis: Unlocking Precision in Bone & In

  2026-07-27

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, is redefining experimental approaches to bone and inflammation research by enabling precise modulation of fatty acid epoxide signaling. Discover novel insights into the sEH–Nrf2 pathway and practical assay strategies that set this article apart.

• Ivermectin: Mechanistic Precision and Emerging Roles in Para

  2026-07-27

  Explore the advanced mechanisms and research-grade applications of Ivermectin, a broad-spectrum anti-parasitic, with in-depth analysis of its utility in parasitology drug development. This article uniquely bridges mechanistic insight and protocol optimization for translational research.

450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page